Status:
COMPLETED
Demographical and Clinical Profile of Patients With Left Ventricular Hypertrophy
Lead Sponsor:
Cardiovascular Academy Society, Turkey
Conditions:
Left Ventricular Hypertrophy
Eligibility:
All Genders
18-90 years
Brief Summary
Left ventricular hypertrophy (LVH) is the most common result of the heart trying to pump blood against the high afterload, as in hypertension and aortic stenosis.Although hypertension is the most comm...
Detailed Description
Left ventricular hypertrophy (LVH) is an abnormal increase in the mass of the left ventricular (LV) myocardium caused by a chronic increased workload in the heart.This is most common result of the hea...
Eligibility Criteria
Inclusion
- Patients who have undergone ECG / ECO within the last 6 months and have been found to meet LVH according to the specified criteria
- older than 18 years and younger than 90 years
- who signed the informed consent form
Exclusion
- Cases without optimal electro or echocardiographic examination due to limited echogenicity
Key Trial Info
Start Date :
February 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
886 Patients enrolled
Trial Details
Trial ID
NCT04275882
Start Date
February 14 2020
End Date
December 1 2021
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yasemin
Kayseri, Eyalet/Yerleşke, Turkey (Türkiye), 38000